Literature DB >> 974234

Selected ion monitoring assay for the bronchodilator pirbuterol.

F C Falkner, H M McIlhenny.   

Abstract

A selected ion monitoring assay has been developed to measure plasma levels of the bronchodilator pirbuterol in animals and man. Pirbuterol is extracted from plasma with acetone + potassium carbonate and after further purification is converted to its trimethylacetyl derivative. With the use of the stable isotope labeled internal standard, pirbuterol-d9, precisions of 10% and 6% were achieved at plasma concentrations of 1 and 20 ng ml-1, respectively. The synthesis of the deuterium labeled internal standard is described.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 974234     DOI: 10.1002/bms.1200030503

Source DB:  PubMed          Journal:  Biomed Mass Spectrom        ISSN: 0306-042X


  5 in total

Review 1.  Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease.

Authors:  D M Richards; R N Brogden
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

2.  Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.

Authors:  J R Dawson; R Canepa-Anson; P Kuan; N H Whitaker; J Carnie; C Warnes; S R Reuben; P A Poole-Wilson; G C Sutton
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-02

3.  Effects of pirbuterol and sodium nitroprusside on pulmonary haemodynamics in hypoxic cor pulmonale.

Authors:  W MacNee; C G Wathen; W J Hannan; D C Flenley; A L Muir
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-22

4.  Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.

Authors:  J R Dawson; R Canepa-Anson; P Kuan; S R Reuben; P A Poole-Wilson; G C Sutton
Journal:  Br Heart J       Date:  1983-09

5.  Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure.

Authors:  R Canepa-Anson; J R Dawson; P Kuan; P A Poole-Wilson; G C Sutton; B Cockrill; S R Reuben
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.